Fortrea Holdings Inc.
FTRENasdaq
$17.76
↓ -0.9%Jul 17 close · end-of-day
Price
1Y↑ +262.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.7B
Enterprise Value
$2.6B
P/E
—
P/S
0.6
P/B
3.2
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$2.7B
Net Income (TTM)
-$449.7M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
-13.1%
Net Margin
-16.6%
ROE
-85.5%
ROIC
-19.6%
Debt / Equity
2.0
Net Cash
-$906.0M
Return 1Y
+258.8%
Company profile
Fortrea is a leading global contract research organization (CRO) helping customers bring life-changing solutions to patients faster. With over 19,000 professionals conducting operations in more than 90 countries, Fortrea is transforming drug and device development for partners and patients across the globe.
- CEO
- Tom Pike
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- North Carolina
- Website
- www.fortrea.com
Management & directors
- Morais Mark A.Chief Operating Officer
- Mcconnell Jill G.Chief Financial Officer
- Parks RobertChief Accounting Officer
- Hanson James S.General Counsel
Roles derived from SEC Form 4 filings.
Earnings
FTRE Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$636.5M↓ -2.3%
Diluted EPS-$0.25↓ -96.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.1B | $2.8B | $2.8B | $2.7B | $2.7B |
| Gross profit | — | — | — | — | — |
| Operating income | $114.3M | $187.1M | $32.0M | -$161.9M | -$872.6M |
| Net income | $98.0M | $186.2M | -$25.0M | -$329.0M | -$989.0M |
| Diluted EPS | $1.10 | $2.09 | -$0.29 | -$3.67 | -$10.81 |
| Operating cash flow | $169.8M | $82.7M | $168.4M | $262.8M | $113.5M |
| Free cash flow | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating margin | 3.7% | 6.6% | 1.1% | -6.0% | -32.0% |
| Net margin | 3.2% | 6.6% | -0.9% | -12.2% | -36.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $662.4M | $674.9M | $697.0M | $651.3M | $710.3M | $701.3M | $660.5M | $636.5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$50.9M | -$18.0M | -$55.6M | -$520.1M | -$330.3M | -$8.6M | -$13.6M | -$3.4M |
| Net income | -$138.4M | -$27.9M | -$61.7M | -$562.9M | -$374.9M | -$15.9M | -$35.3M | -$23.6M |
| Diluted EPS | -$1.55 | -$0.31 | -$0.68 | -$6.25 | -$4.14 | -$0.17 | -$0.25 | -$0.25 |
| Operating cash flow | $273.7M | -$2.4M | $17.1M | -$124.2M | $21.8M | $86.8M | $129.1M | -$17.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -7.7% | -2.7% | -8.0% | -79.9% | -46.5% | -1.2% | -2.1% | -0.5% |
| Net margin | -20.9% | -4.1% | -8.9% | -86.4% | -52.8% | -2.3% | -5.3% | -3.7% |
Company news
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | Smith David Ross | Tax withholding | 18,244 | $16.34 | $298,106.96 | filing |
| 2026-06-10 | Morais Mark A.· Chief Operating Officer | Sale | 4,674 | $16.82 | $78,616.68 | filing |
| 2026-06-10 | Pesicka Edward A | Option exercise | 38,817 | $0.00 | $0.00 | filing |
| 2026-06-10 | Ray Amrit | Option exercise | 38,817 | $0.00 | $0.00 | filing |
| 2026-06-10 | Russell Erin L | Option exercise | 38,817 | $0.00 | $0.00 | filing |
| 2026-06-10 | SANDERS MACHELLE | Option exercise | 38,817 | $0.00 | $0.00 | filing |
| 2026-06-10 | Smith David Ross | Option exercise | 38,817 | $0.00 | $0.00 | filing |
| 2026-06-02 | Morais Mark A.· Chief Operating Officer | Sale | 4,866 | $15.49 | $75,374.34 | filing |
| 2026-06-02 | Mcconnell Jill G.· Chief Financial Officer | Sale | 4,866 | $15.49 | $75,374.34 | filing |
| 2026-06-01 | Morais Mark A.· Chief Operating Officer | Option exercise | 11,006 | $0.00 | $0.00 | filing |
| 2026-06-01 | Mcconnell Jill G.· Chief Financial Officer | Option exercise | 11,006 | $0.00 | $0.00 | filing |
| 2026-05-18 | Parks Robert· Chief Accounting Officer | Sale | 2,000 | $13.44 | $26,880.00 | filing |
| 2026-05-14 | NEUPERT PETER M | Option exercise | 148,536 | $0.00 | $0.00 | filing |
| 2026-03-20 | Russell Erin L | Option exercise | 23,946 | $0.00 | $0.00 | filing |
| 2026-03-16 | Mcconnell Jill G.· Chief Financial Officer | Sale | 1,804 | $9.22 | $16,632.88 | filing |
| 2026-03-16 | Morais Mark A.· Chief Operating Officer | Sale | 1,804 | $9.22 | $16,632.88 | filing |
| 2026-03-13 | Mcconnell Jill G.· Chief Financial Officer | Option exercise | 4,284 | $0.00 | $0.00 | filing |
| 2026-03-13 | Morais Mark A.· Chief Operating Officer | Option exercise | 4,284 | $0.00 | $0.00 | filing |
| 2026-03-10 | Mcconnell Jill G.· Chief Financial Officer | Sale | 2,531 | $9.21 | $23,310.51 | filing |
| 2026-03-10 | Mcconnell Jill G.· Chief Financial Officer | Sale | 2,530 | $8.93 | $22,592.90 | filing |
| 2026-03-10 | Morais Mark A.· Chief Operating Officer | Sale | 2,300 | $9.21 | $21,183.00 | filing |
| 2026-03-10 | Morais Mark A.· Chief Operating Officer | Sale | 2,299 | $8.93 | $20,530.07 | filing |
| 2026-03-10 | Parks Robert· Chief Accounting Officer | Sale | 964 | $9.21 | $8,878.44 | filing |
| 2026-03-10 | Parks Robert· Chief Accounting Officer | Sale | 963 | $8.93 | $8,599.59 | filing |
| 2026-03-09 | Parks Robert· Chief Accounting Officer | Option exercise | 5,270 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.